Like Ingenuity Systems

closed 4/29/2013 via PR Newswire

Qiagen N.V., acquired Ingenuity Systems

synopsis: QIAGEN N.V. announced the acquisition of Ingenuity Systems, Inc., the leading provider of software solutions to efficiently and accurately analyze and interpret the biological meaning of genomic data. The foundation of Ingenuity's product portfolio is the Ingenuity Knowledge Base, an effort to structure the vast amount of biomedical literature.
buyer: Qiagen N.V. (QGEN:$1,269.61)
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies, used to transform biological materials into valuable molecular information. Qiagen has four customer classes: Molecular Diagnostics, Applied Testing, Pharma, & Academia. "
target: Ingenuity Systems
Ingenuity Systems is the global market leader in web-based applications to quickly analyze and accurately interpret rapidly growing volumes of genomic data. The Ingenuity Knowledge Base is built on algorithms that pair all human gene variants with biological interpretations based on known outcomes.
price ($mm)
$109
rev ($mm)
$20
EBITDA ($mm)
EV / rev
5.5x
EV / EBITDA
closed 11/24/2020 via BusinessWire

Transaction Data Systems, acquired KloudScript, Inc.

synopsis: Transaction Data Systems (TDS), the leader in pharmacy software solutions for the community pharmacy market, has acquired KloudScript, a specialty pharmacy care solution. Combining KloudScript’s capabilities with TDS' market-leading solutions will empower its pharmacists to expand into specialty medication offerings.
buyer parent: GTCR, LLC
buyer: Transaction Data Systems
Transaction Data Systems (TDS), with its portfolio of products and services including Rx30, Computer-Rx, Enhanced Medication Services, and Pharm Assess, provides pharmacy management systems and innovative technology solutions to the pharmacy industry. "
target: KloudScript, Inc.
KloudScript is a digital health network focused on providing technology and support services for specialty medications. KloudScript’s innovative technology platforms KETU and ProntoRx offer pharmacies and prescribers an efficient patient care management workflow solution and simplify patient care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/6/2012 via BusinessWire

MeadWestvaco Corporation, acquired AARDEX Group SA

synopsis: MeadWestvaco Corporation announced that it is expanding its leading position in adherence packaging with the acquisition of AARDEX Group SA. AARDEX is the leader and pioneer in the design and use of electronic medication event monitoring systems and applications designed to measure, analyze, and manage patient adherence in clinical drug trials.
buyer: MeadWestvaco Corporation (WRK:$6,049.00)
MeadWestvaco Corporation provides packaging solutions to many of the world’s most-admired brands in the healthcare, beauty and personal care, food, beverage, home and garden, and tobacco industries. "
target: AARDEX Group SA
AARDEX Group is the pioneer and world leader in developing, manufacturing, and marketing MEMS™, Medication Event Monitoring System, which measures, analyzes and facilitates patients' adherence to prescribed drug dosing regimens in clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2013 via PR Newswire

The WIRB-Copernicus Group, acquired IRBNet

synopsis: Arsenal Capital Partners, a private equity firm that invests in middle market healthcare and specialty industrial companies, announced the acquisition by its portfolio company, The WIRB-Copernicus Group, of Research Dataware, LLC, software developer and provider of IRBNet, the leading software application supporting institutional review boards.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
With more than 60 years of combined experience reviewing research protocols and study-related information, it is the mission of The WIRB-Copernicus Group to meet the highest standards of ethics and science, and to ensure the safety and welfare of subjects worldwide. "
target: IRBNet
IRBNet offers the world's leading and most widely used electronic solution for managing research compliance for institutions of any size, with more than 1,600 large, medium and small research institutions, boards and research sites registered on the National Research Network®.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2008 via PR Newswire

United BioSource Corporation, acquired Envision Pharma, Inc.

synopsis: United BioSource Corporation acquired Envision Pharma, a leading scientific communications and technology company. With a focus on the pharmaceutical and biotechnology industry, Envision integrates scientific communication services and targeted software applications.
buyer parent: Oak Investment Partners
buyer: United BioSource Corporation
United BioSource Corporation accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies. "
target: Envision Pharma, Inc.
Envision Pharma is an innovative scientific communications and technology company providing commercially focused, strategically driven scientific and technology solutions to the pharmaceutical, biotechnology and device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/1/2021 via BusinessWire

Instem, acquired The Edge Software Consultancy Ltd.

synopsis: Instem, a leading provider of IT solutions and services to the global life sciences market, has acquired The Edge Software Consultancy Ltd., a UK-based software company specializing in the pharmaceutical and biotechnology industry. The Edge focuses on improving the efficiency of drug discovery research and development.
buyer: Instem (AIM:INS:$38.90)
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide. "
target: The Edge Software Consultancy Ltd.
The Edge is a UK-based software company specializing in the pharmaceutical and biotechnology industry. The Edge focuses on improving the efficiency of drug discovery research and development. Their BioRails platform enables automated data capture over the entire research and development process.
price ($mm)
$7.88
rev ($mm)
$3
EBITDA ($mm)
EV / rev
3.1x
EV / EBITDA
closed 11/25/2020 via Company Press Release

Advarra, acquired Longboat Clinical Ltd.

synopsis: Advarra, the market leader in regulatory review solutions and clinical site technologies, is pleased to announce the acquisition of Longboat, an innovative provider of clinical trial technologies focused on site training, protocol compliance, and patient engagement.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target: Longboat Clinical Ltd.
Longboat is an innovative provider of user-friendly, fully mobile clinical research technology solutions that take the complexity out of trials for site staff, patients, monitors, and study teams, making protocol compliance easy and instinctive.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/2/2020 via Company Press Release

Cytel Inc., acquired Laiya Consulting, Inc.

synopsis: Cytel Inc. has announced the acquisition of Laiya Consulting, a drug development solutions company specializing in Bayesian adaptive trial designs and implementation. Laiya pioneered the delivery of trial design software using SaaS, which aligns with Cytel’s goal of making all of its design software available as a cloud-based service.
buyer parent: New Mountain Capital, LLC
buyer: Cytel Inc.
Cytel provides statistical software for clinical trials. Cytel provides an understanding of software tools that solve statistical problems and that meet the highest standards of reliability, technical documentation and customer support. "
target: Laiya Consulting, Inc.
Founded in 2010, Laiya Consulting has supported drug developers to drive success rates and maximize portfolio returns through the design and implementation of Bayesian adaptive trials, robust clinical strategies, and integrated software platforms.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/17/2019 via Company Press Release

Nordic Capital, will acquire Aris Global LLC

synopsis: Nordic Capital, a leading private equity investor in the Nordic region, will be acquiring ArisGlobal, a visionary technology company that has successfully developed a next-generation platform that uses advanced cognitive computing and machine learning to automate all core functions of drug safety, regulatory compliance and medical affairs.
buyer: Nordic Capital
Nordic Capital is a leading private equity investor in the Nordic region with a resolute commitment to creating stronger, sustainable businesses through operational improvement and transformative growth. "
target: Aris Global LLC
ArisGlobal is transforming the way most successful life sciences companies develop breakthroughs. Their end-to-end drug development technology platform, LifeSphere, integrates their proprietary Nava cognitive computing engine to automate all core functions of the drug development lifecycle.
price ($mm)
$700
rev ($mm)
$100
EBITDA ($mm)
EV / rev
7.0x
EV / EBITDA
closed 5/17/2012 via PR Newswire

Accelrys Software Inc., purchased Hit Explorer Operating System (HEOS) from SCYNEXIS, Inc.

synopsis: Accelrys, Inc. announced that it has purchased the Web-based Hit Explorer Operating System (HEOS) from SCYNEXIS, Inc. HEOS enables more efficient and streamlined drug discovery collaborations, particularly for organizations leveraging academic departments, research institutes and contract research organizations in externalized R&D projects.
buyer: Accelrys Software Inc. (ACCL:$166.25)
Accelrys, Inc. is a leading scientific enterprise R&D software and services company that supports industries and organizations that rely on scientific innovation to differentiate themselves. Headquartered in San Diego, Calif., Accelrys employs more than 200 full-time PhD scientists. "
seller: SCYNEXIS, Inc.
HEOS® is a comprehensive web-based drug research information management software platform that supports geographically-distributed scientists and facilitates collaboration. It is heavily used by users around the world including large pharmaceutical companies and biotechnology companies.
price ($mm)
$4.50
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/30/2019 via BusinessWire

Evidera, will acquire Medimix International

synopsis: Evidera, a business unit of PPD, LLC, and a provider of evidence-based solutions demonstrating the real-world effectiveness and safety of health care products, will acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries.
buyer parent: Carlyle Group
buyer: Evidera
Evidera, a PPD business unit, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of health care products. They help biopharmaceutical, biotechnology and medical device companies generate the evidence needed to optimize the market access. "
target: Medimix International
Medimix International specializes in providing business understanding, real-world evidence insights to the pharmaceutical and medical device industries. Medimix’s primary solution, LiveTracker™, is a cloud-based platform that provides real-time monitoring of clients’ particular therapeutic markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/11/2018 via Company Press Release

Genpact Ltd, will acquire Commonwealth Informatics Inc.

synopsis: Genpact, a professional services firm focused on delivering digital transformation, announced that it has signed a definitive agreement to acquire Commonwealth Informatics, Inc. (CI), a market-leading provider of cloud-based drug safety analytics products and services for medical research and healthcare delivery headquartered near Boston, Mass.
buyer: Genpact Ltd (G:$3,699.55)
Genpact is a global professional services firm that makes business transformation real. They drive digital-led innovation and digitally-enabled intelligent operations for their clients. They think with design, dream in digital, and solve problems with data and analytics. "
target: Commonwealth Informatics Inc.
Commonwealth Informatics provides cloud-based drug safety analytics products and services for medical research and healthcare delivery. Their Commonwealth Vigilance Workbench consists of integrated modules used by pharmaceutical and biotech companies, government agencies, and healthcare providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2014 via PR Newswire

Decision Resources Group, acquired Relay Technology Management

synopsis: Piramal Enterprises' Information Management Subsidiary, Decision Resources Group, one of the world's leading research and advisory firms focusing on high-value healthcare insights and analytics, announced that it acquired Relay Technology Management, a data analytics company focused on the life-sciences industry.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Relay Technology Management
Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief: that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/30/2021 via BNC Analysis

CSAM Health AS, acquired MedSciNet

synopsis: CSAM Health Group AS, the leading provider of niche eHealth solutions in the Nordics, announced that they have acquired MedSciNet AB, a provider of benchmark eHealth solutions within clinical research.
buyer: CSAM Health AS (OB:CSAM:$30.36)
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. "
target: MedSciNet
MedSciNet is a Stockholm based company specialising in design and development of web applications and on-line database systems for clinical trials and studies, quality registries, medical bio-banks, and other solutions within the medical field.
price ($mm)
$2.88
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
announced 5/27/2021 via PR Newswire

Thoma Bravo, LLC, will acquire Greenphire, Inc

synopsis: Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.
buyer: Thoma Bravo, LLC
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make acquisitions intended to accelerate revenue and earnings. "
target parent: The Riverside Company
target: Greenphire, Inc
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2021 via GlobeNewswire

Scarritt Group Inc., acquired TrialTech Medical Inc.

synopsis: Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, has acquired TrialTech Medical Inc, a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials.
buyer: Scarritt Group Inc.
Scarritt Group is a technology-enabled, full service meeting planning and logistics company specializing in delivering clinical trial meetings worldwide. "
target: TrialTech Medical Inc.
TrialTech Medical is a software and services company supporting the pharmaceutical, biotechnology and medical device industries. They work in coordination with their clients' medical and clinical operations teams to optimize the process of clinical trial planning, recruitment and enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2019 via BNC Analysis

TrialScope, acquired Clinical Trial Connect, LLC

synopsis: TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will share his technological expertise as part of the TrialScope team.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
target: Clinical Trial Connect, LLC
Clinical Trial Connect is a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. Clinical Trial Connect was founded by Mike Wenger, who developed his own algorithm for matching patients to clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2019 via BNC Analysis

JLL Partners, Water Street Healthcare Partners, acquired THREAD Research

synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer: JLL Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target: THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
closed 4/29/2013 via PR Newswire

Qiagen N.V., acquired Ingenuity Systems

synopsis: QIAGEN N.V. announced the acquisition of Ingenuity Systems, Inc., the leading provider of software solutions to efficiently and accurately analyze and interpret the biological meaning of genomic data. The foundation of Ingenuity's product portfolio is the Ingenuity Knowledge Base, an effort to structure the vast amount of biomedical literature.
buyer: Qiagen N.V. (QGEN:$1,269.61)
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies, used to transform biological materials into valuable molecular information. Qiagen has four customer classes: Molecular Diagnostics, Applied Testing, Pharma, & Academia. "
target: Ingenuity Systems
Ingenuity Systems is the global market leader in web-based applications to quickly analyze and accurately interpret rapidly growing volumes of genomic data. The Ingenuity Knowledge Base is built on algorithms that pair all human gene variants with biological interpretations based on known outcomes.
price ($mm)
$109
rev ($mm)
$20
EBITDA ($mm)
EV / rev
5.5x
EV / EBITDA
closed 1/9/2017 via Company Press Release

Qiagen N.V., acquired OmicSoft Corporation

synopsis: QIAGEN N.V. announced the acquisition of OmicSoft Corporation, providing access to OmicSoft’s powerful multi-omics data management infrastructure solution as well as expertly curated ‘omics’ data sets that complement QIAGEN’s bioinformatics portfolio that are relied upon by customers worldwide to gain valuable insights into complex biological data.
buyer: Qiagen N.V. (QGEN:$1,269.61)
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies, used to transform biological materials into valuable molecular information. Qiagen has four customer classes: Molecular Diagnostics, Applied Testing, Pharma, & Academia. "
target: OmicSoft Corporation
OmicSoft is recognized for its suite of cutting-edge software solutions that enable scientists and researchers to efficiently analyze and visualize their own data sets and compare them to massive volumes of publicly available ‘omics’ data sets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/30/2013 via BNC Analysis

Qiagen N.V., acquired CLC bio A/S

synopsis: Qiagen, a Netherlands holding company that ia a leading global provider of Sample & Assay Technologies, used to transform biological materials into valuable molecular information, acquired CLC bio, a global leader in bioinformatics software with a focus on next-generation sequencing (NGS).
buyer: Qiagen N.V. (QGEN:$1,269.61)
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies, used to transform biological materials into valuable molecular information. Qiagen has four customer classes: Molecular Diagnostics, Applied Testing, Pharma, & Academia. "
target: CLC bio A/S
CLC bio is the world's leading bioinformatics solution provider and the only one that provides both desktop and server software seamlessly integrated and optimized for best performance. The company is headquarted in Aarhus, Denmark.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/29/2013 via PR Newswire

Qiagen N.V., acquired Ingenuity Systems

synopsis: QIAGEN N.V. announced the acquisition of Ingenuity Systems, Inc., the leading provider of software solutions to efficiently and accurately analyze and interpret the biological meaning of genomic data. The foundation of Ingenuity's product portfolio is the Ingenuity Knowledge Base, an effort to structure the vast amount of biomedical literature.
buyer: Qiagen N.V. (QGEN:$1,269.61)
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies, used to transform biological materials into valuable molecular information. Qiagen has four customer classes: Molecular Diagnostics, Applied Testing, Pharma, & Academia. "
target: Ingenuity Systems
Ingenuity Systems is the global market leader in web-based applications to quickly analyze and accurately interpret rapidly growing volumes of genomic data. The Ingenuity Knowledge Base is built on algorithms that pair all human gene variants with biological interpretations based on known outcomes.
price ($mm)
$109
rev ($mm)
$20
EBITDA ($mm)
EV / rev
5.5x
EV / EBITDA

Like Ingenuity Systems


read more

Ingenuity Systems

KloudScript, Inc.

AARDEX Group SA

Viedoc

IRBNet

Envision Pharma, Inc.

The Edge Software Consultancy Ltd.

Longboat Clinical Ltd.

Laiya Consulting, Inc.

Aris Global LLC

SCYNEXIS, Inc.

Medimix International

Commonwealth Informatics Inc.

Relay Technology Management

MedSciNet

Greenphire, Inc

TrialTech Medical Inc.

Clinical Trial Connect, LLC

THREAD Research

OmniComm Systems, Inc.

read more

Ingenuity Systems

read more

OmicSoft Corporation

CLC bio A/S

Ingenuity Systems

read more
Geography
Matching Companies
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: CHNG
 
 
 
 
 
 
 
 
Change Healthcare Corporation
Change Healthcare Corporation
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
year
2020
rev ($mm)
$1,646.91
EBITDA ($mm)
EBIT ($mm)
($155.95)
Net Income ($mm)
Employees
15000
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: PKI
 
 
 
 
 
 
 
 
PerkinElmer, Inc.
PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. It designs, manufactures and delivers advanced technology solutions that address the world's most critical health and safety concerns.
year
2014
rev ($mm)
$2,209.40
EBITDA ($mm)
$414.31
EBIT ($mm)
$289.91
Net Income ($mm)
$191.79
Employees
7561
  • drill down
  • watch
Ticker: QGEN
 
 
 
 
 
 
 
 
Qiagen N.V.
Qiagen N.V.
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies, used to transform biological materials into valuable molecular information. Qiagen has four customer classes: Molecular Diagnostics, Applied Testing, Pharma, & Academia.
year
2013
rev ($mm)
$1,269.61
EBITDA ($mm)
$399.44
EBIT ($mm)
$208.51
Net Income ($mm)
$35.80
Employees
4000
  • drill down
  • watch
Ticker: AIM:CRON
 
 
 
 
 
 
 
 
Cronin Group PLC
Cronin Group PLC provides medical research and development services. The Company focuses on the discovery, development, and manufacture of small molecules and nano-materials utilizing proprietary chemistry. Cronin Group offers its services in the United Kingdom.
year
2018
rev ($mm)
EBITDA ($mm)
($2.29)
EBIT ($mm)
($2.34)
Net Income ($mm)
Employees
25
  • drill down
  • watch
Ticker: CLDA
 
 
 
 
 
 
 
 
Clinical Data, Inc.
Clinical Data, Inc.
Clinical Data, Inc. provides a full range of products and services to the growing domestic Physician Office Laboratory market and to smaller laboratories internationally & also provides a complete range of products and services for the Physician Office Laboratory and hospital laboratory market.
year
2010
rev ($mm)
$13.09
EBITDA ($mm)
($78.85)
EBIT ($mm)
($81.80)
Net Income ($mm)
Employees
160
  • drill down
  • watch
Ticker: BEAT
 
 
 
 
 
 
 
 
BioTelemetry
BioTelemetry
BioTelemetry, Inc. is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The company currently provides cardiac monitoring services, original equipment manufacturing and more.
year
2019
rev ($mm)
$386.46
EBITDA ($mm)
$110.26
EBIT ($mm)
$69.90
Net Income ($mm)
$48.52
Employees
1500
  • drill down
  • watch